Blood test flags booze risk; sedative may stop ICU brain fog
NCT ID NCT07428681
First seen Feb 27, 2026 · Last updated May 24, 2026 · Updated 13 times
Summary
This study tests whether giving a low dose of lorazepam (a sedative) early on can prevent delirium—a state of severe confusion—in intensive care patients who are at higher risk because of heavy alcohol use. Researchers will use a blood test (Anttila-Index) to identify these patients within 24 hours of ICU admission. About 260 adults will be randomly assigned to receive either lorazepam or a placebo to see if the drug reduces the number of people who develop delirium.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM CONFUSIONAL STATE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.